Longboard Pharmaceuticals, Inc. Cash Flow from Operating Activities
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
| Cash Flow from Operating Activities | ($3,442.0K) | ($24.7M) | ($38.1M) | ($50.9M) |
Longboard Pharmaceuticals, Inc. (LBPH) Cash Flow from Operating Activities comparison analysis
General
LTM Cash Flow from Operating Activities
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
LBPH key stats
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
% growth | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.0 | 0.0 |
% margin | 0.0 0.0% | (0.0) 0.0% | (0.0) 0.0% | (0.0) 0.0% |
| Operating Expenses | 14.4 | 27.8 | 44.8 | 56.8 |
| Research & Development Expenses (R&D) | 4.6 | 19.8 | 34.6 | 43.8 |
| Selling, General & Administrative Expenses (SG&A) | 9.8 | 8.1 | 10.2 | 13.0 |
% margin | (14.4) 0.0% | (27.8) 0.0% | (44.8) 0.0% | (56.8) 0.0% |
| Interest Income | 0.0 | 0.1 | 0.8 | 2.4 |
| Interest Expense | 0.0 | 0.0 | 0.8 | 0.0 |
| Pre-tax Income | (14.4) | (27.8) | (43.9) | (54.4) |
% effective tax rate | (0.0) 0.1% | (0.1) 0.2% | (0.9) 1.9% | 0.0 0.0% |
% margin | (14.4) 0.0% | (27.7) 0.0% | (43.1) 0.0% | (54.4) 0.0% |
| EPS | (0.82) | (1.62) | (2.51) | (2.39) |
| Diluted EPS | (0.82) | (1.62) | (2.51) | (2.39) |
% margin | (14.4) 0.0% | (27.8) 0.0% | (44.8) 0.0% | (56.8) 0.0% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Longboard Pharmaceuticals, Inc.'s Cash Flow from Operating Activities?
As of today, Longboard Pharmaceuticals, Inc.'s last 12-month Cash Flow from Operating Activities is ($65.9M), based on the financial report for Sep 30, 2024 (Q3’2024).
2) What is Longboard Pharmaceuticals, Inc.'s Cash Flow from Operating Activities growth rate?
Over the last year, Longboard Pharmaceuticals, Inc.'s Cash Flow from Operating Activities growth was 33.2%. The average annual Cash Flow from Operating Activities growth rates for Longboard Pharmaceuticals, Inc. have been 80.8% over the past three years, 342.2% over the past five years.
3) Is Longboard Pharmaceuticals, Inc.'s Cash Flow from Operating Activities growth rate Good?
Over the last year, Longboard Pharmaceuticals, Inc.'s Cash Flow from Operating Activities growth was 33.2%, which is higher than industry growth of (0.0%). It indicates that Longboard Pharmaceuticals, Inc.'s Cash Flow from Operating Activities growth is Good.